Literature DB >> 12084326

The use of lasers in benign prostatic enlargement.

T A McNicholas1, S Singh.   

Abstract

This article reviews the laser techniques available for the treatment of lower urinary tract symptoms. Early data on short-term mortality, morbidity, complication rates, and outcome are available, but information on cost-effectiveness, long-term outcome, and patient preference are as yet unavailable. In the 8 years since laser methods became popular it has become clear that substantial and variably durable flow and symptomatic responses are achieved that do not quite match transurethral resection of the prostate (TURP). Less immediate physiologic stress is balanced by a delay before full response. Same-day surgery may be possible, but an extended period of catheterization may be necessary. Laser methods remain an option for treatment and are particularly applicable to the less fit man. Whether men will choose a less effective but less invasive treatment option for symptom relief is not yet obvious. Limited early data suggest the holmium laser technique most closely approaches the gold standard.

Entities:  

Mesh:

Year:  2000        PMID: 12084326     DOI: 10.1007/s11934-000-0047-8

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  43 in total

1.  Visual laser ablation of the prostate: efficacy evaluated by urodynamics and compared to TURP.

Authors:  P Jung; P Mattelaer; J M Wolff; A Mersdorf; G Jakse
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

2.  Transurethral evaporation of the prostate for treatment of benign prostatic hyperplasia: results in 168 patients with up to 12 months of followup.

Authors:  P Narayan; A Tewari; E Schalow; R Leidich; S Aboseif; C Cascione
Journal:  J Urol       Date:  1997-04       Impact factor: 7.450

3.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.

Authors:  N P Roos; J E Wennberg; D J Malenka; E S Fisher; K McPherson; T F Andersen; M M Cohen; E Ramsey
Journal:  N Engl J Med       Date:  1989-04-27       Impact factor: 91.245

4.  K.T.P. 532 laser in treatment of urethral strictures.

Authors:  A Shanberg; R Baghdassarian; L Tansey; D Sawyer
Journal:  Urology       Date:  1988-12       Impact factor: 2.649

5.  Hybrid laser treatment compared with transurethral resection of the prostate for symptomatic bladder outlet obstruction caused by a large benign prostate: a prospective, randomized trial with a 6-month follow-up.

Authors:  K Tuhkanen; A Heino; M Alaopas
Journal:  BJU Int       Date:  1999-11       Impact factor: 5.588

6.  Preliminary study of the action of the Yag laser on canine prostatic adenoma and experimental urethral stenosis.

Authors:  M Camey; A Le Duc
Journal:  Eur Urol       Date:  1980       Impact factor: 20.096

7.  A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up.

Authors:  A Carter; H Sells; M Speakman; P Ewings; R MacDonagh; P O'Boyle
Journal:  BJU Int       Date:  1999-02       Impact factor: 5.588

8.  High prevalence of benign prostatic hypertrophy in the community.

Authors:  W M Garraway; G N Collins; R J Lee
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

9.  Laser therapy in dogs and humans--is there a difference?

Authors:  H W Gottfried; E Brändle; R Hefty; T Mattfeldt; W Badura; U Vogel; R E Hautmann
Journal:  Br J Urol       Date:  1997-03

10.  Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience.

Authors:  P J Gilling; C B Cass; A R Malcolm; M R Fraundorfer
Journal:  J Endourol       Date:  1995-04       Impact factor: 2.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.